Silver nanoparticles composition for treatment of distemper in dogs Online publication date: Thu, 04-Feb-2016
by Nina Bogdanchikova; Roberto Vázquez-Muñoz; Alejandro Huerta-Saquero; Antonio Pena-Jasso; Gildardo Aguilar-Uzcanga; Paola L. Picos-Díaz; Alexey Pestryakov; Vasilii Burmistrov; Oxana Martynyuk; Roberto Luna-Vázquez-Gómez; Horacio Almanza
International Journal of Nanotechnology (IJNT), Vol. 13, No. 1/2/3, 2016
Abstract: Canine distemper is caused by the canine distemper virus (CDV), a paramyxovirus of the genus Morbillivirus, with a worldwide distribution. Canine distemper is a multisystem disease, potentially fatal. Affected organisms may develop clinical or subclinical infections, among them respiratory, gastrointestinal and of the nervous system. In the present work, we use a veterinary pharmaceutical composition of silver nanoparticles (AgNPs) for the treatment of distemper in dogs with neurological and non-neurological symptoms. AgNPs treatment of animals with non-neurological distemper provides a very high rate of recovery without sequelae. However, in dogs with neurological symptoms, AgNPs treatment was not able to reverse the disease.
Online publication date: Thu, 04-Feb-2016
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanotechnology (IJNT):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email firstname.lastname@example.org